Search companies or stocks...
LVTXLAVA Therapeutics N.V.
At close · 28 Nov 2025, 09:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio…
Current stock price of LAVA Therapeutics N.V. (LVTX) stock is $1.740. The stock price is -3.87% lower in the session. The intraday range can be seen from this page. Volume of LAVA Therapeutics N.V. (LVTX) stock is 285.52K.
Last updated at 28 Nov 2025, 09:00 pm.
The stock price of LAVA Therapeutics N.V. (LVTX) can change with earnings, company news, and overall market sentiment. LAVA Therapeutics N.V. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether LAVA Therapeutics N.V. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for LVTX on this page is -2.00. EPS on this page is -0.87. Compare those figures with peers and growth expectations before deciding if the current LAVA Therapeutics N.V. price is justified.
Historical performance for LAVA Therapeutics N.V. (LVTX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how LVTX reacted to past earnings and market events.
Buying LAVA Therapeutics N.V. (LVTX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
